Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Epigenetic associations in relation to cardiovascular prevention and therapeutics

Fig. 1

Potential epigenetic mechanisms (DNA methylation, histone alteration, RNA-based mechanisms) and compounds involved in cardiovascular disease. ACE angiotensin-converting enzyme, ANRIL anti-sense non-coding RNA, ANRIL anti-sense non-coding RNA in the INK4 locus, ASA acetylsalicylic acid, ASOs anti-sense oligonucleotides, CHD coronary heart disease, CVD cardiovascular disease, DAC 5-aza-2-deoxycytidinedemethylating agent, DNMT DNA methyltransferase, eNOS endothelial nitric oxide synthase, FENDRR FOXF1 adjacent non-coding developmental regulatory RNA, HAT histone acetyltransferase, HDAC histone deacetylase, lncRNA long non-coding RNA, miRNA microRNA, NO nitric oxide

Back to article page